1. Home
  2. DSX vs SPRO Comparison

DSX vs SPRO Comparison

Compare DSX & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSX
  • SPRO
  • Stock Information
  • Founded
  • DSX 1999
  • SPRO 2013
  • Country
  • DSX Greece
  • SPRO United States
  • Employees
  • DSX N/A
  • SPRO N/A
  • Industry
  • DSX Marine Transportation
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • DSX Consumer Discretionary
  • SPRO Health Care
  • Exchange
  • DSX Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • DSX 172.5M
  • SPRO 162.1M
  • IPO Year
  • DSX 2005
  • SPRO 2017
  • Fundamental
  • Price
  • DSX $1.59
  • SPRO $2.40
  • Analyst Decision
  • DSX
  • SPRO Buy
  • Analyst Count
  • DSX 0
  • SPRO 4
  • Target Price
  • DSX N/A
  • SPRO $5.00
  • AVG Volume (30 Days)
  • DSX 271.2K
  • SPRO 1.1M
  • Earning Date
  • DSX 07-30-2025
  • SPRO 08-04-2025
  • Dividend Yield
  • DSX 2.42%
  • SPRO N/A
  • EPS Growth
  • DSX N/A
  • SPRO N/A
  • EPS
  • DSX 0.05
  • SPRO N/A
  • Revenue
  • DSX $225,498,000.00
  • SPRO $44,584,000.00
  • Revenue This Year
  • DSX N/A
  • SPRO N/A
  • Revenue Next Year
  • DSX $12.09
  • SPRO N/A
  • P/E Ratio
  • DSX $31.26
  • SPRO N/A
  • Revenue Growth
  • DSX N/A
  • SPRO N/A
  • 52 Week Low
  • DSX $1.27
  • SPRO $0.51
  • 52 Week High
  • DSX $2.86
  • SPRO $3.22
  • Technical
  • Relative Strength Index (RSI)
  • DSX 59.05
  • SPRO 42.89
  • Support Level
  • DSX $1.55
  • SPRO $2.45
  • Resistance Level
  • DSX $1.66
  • SPRO $3.22
  • Average True Range (ATR)
  • DSX 0.06
  • SPRO 0.12
  • MACD
  • DSX 0.01
  • SPRO -0.11
  • Stochastic Oscillator
  • DSX 86.36
  • SPRO 3.25

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: